| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |